Eiken syndrome

Last updated
Eiken syndrome
Autosomal recessive - en.svg
This condition is inherited in an autosomal recessive manner

Eiken syndrome, also known as "Eiken skeletal dysplasia", is a rare [1] autosomal bone dysplasia with a skeletal phenotype which has been described in a unique consanguineous family, where it segregates as a recessive trait. [2] [3] First described in 1985, the syndrome primarily affects the development of bones, leading to short stature, long limbs, and joint dislocations. Eiken syndrome is caused by mutations in the PTH1R gene, located on chromosome 3, and is involved in skeletal development. [4] [5]

Contents

Signs and symptoms

Delayed ossification characterizes the Eiken syndrome. [5] Individuals with the syndrome may exhibit various orthopedic issues, including abnormal modeling of the bones in the hands and feet, joint hypermobility, abnormal persistence of cartilage in the pelvis, and mild growth retardation. [6]

Diagnosis

Diagnosis often includes clinical evaluation, radiographic imaging, and genetic testing to identify mutations that may be responsible for the syndrome. The disorder typically becomes evident in infancy or early childhood, and its clinical features may vary among affected individuals. The syndrome is very rare, with the seventh patient reported in 2019. [7]

Related Research Articles

<span class="mw-page-title-main">Osteopetrosis</span> Rare disease of the bones

Osteopetrosis, literally "stone bone", also known as marble bone disease or Albers-Schönberg disease, is an extremely rare inherited disorder whereby the bones harden, becoming denser, in contrast to more prevalent conditions like osteoporosis, in which the bones become less dense and more brittle, or osteomalacia, in which the bones soften. Osteopetrosis can cause bones to dissolve and break.

<span class="mw-page-title-main">Otospondylomegaepiphyseal dysplasia</span> Medical condition

Otospondylomegaepiphyseal dysplasia (OSMED) is an autosomal recessive disorder of bone growth that results in skeletal abnormalities, severe hearing loss, and distinctive facial features. The name of the condition indicates that it affects hearing (oto-) and the bones of the spine (spondylo-), and enlarges the ends of bones (megaepiphyses).

<span class="mw-page-title-main">Spondyloepimetaphyseal dysplasia, Strudwick type</span> Medical condition

Spondyloepimetaphyseal dysplasia, Strudwick type is an inherited disorder of bone growth that results in dwarfism, characteristic skeletal abnormalities, and problems with vision. The name of the condition indicates that it affects the bones of the spine (spondylo-) and two regions near the ends of bones. This type was named after the first reported patient with the disorder. Spondyloepimetaphyseal dysplasia, Strudwick type is a subtype of type II collagenopathies.

An osteochondrodysplasia, or skeletal dysplasia, is a disorder of the development of bone and cartilage. Osteochondrodysplasias are rare diseases. About 1 in 5,000 babies are born with some type of skeletal dysplasia. Nonetheless, if taken collectively, genetic skeletal dysplasias or osteochondrodysplasias comprise a recognizable group of genetically determined disorders with generalized skeletal affection. These disorders lead to disproportionate short stature and bone abnormalities, particularly in the arms, legs, and spine. Skeletal dysplasia can result in marked functional limitation and even mortality.

<span class="mw-page-title-main">Multiple epiphyseal dysplasia</span> Rare genetic disorder

Multiple epiphyseal dysplasia (MED), also known as Fairbank's disease, is a rare genetic disorder that affects the growing ends of bones. Long bones normally elongate by expansion of cartilage in the growth plate near their ends. As it expands outward from the growth plate, the cartilage mineralizes and hardens to become bone (ossification). In MED, this process is defective.

<span class="mw-page-title-main">Pseudoachondroplasia</span> Inherited disorder of bone growth

Pseudoachondroplasia is an inherited disorder of bone growth. It is a genetic autosomal dominant disorder. It is generally not discovered until 2–3 years of age, since growth is normal at first. Pseudoachondroplasia is usually first detected by a drop of linear growth in contrast to peers, a waddling gait or arising lower limb deformities.

Metaphyseal dysplasia, or Pyle disease, is a disorder of the bones. It is a rare disease in which the outer part of the shafts of long bones is thinner than normal and there is an increased chance of fractures. Its hallmark feature is an abnormality of the long bones in the arms and legs in which the ends (metaphyses) of the bones are abnormally broad; the shape of the bones resembles a boat oar or paddle. The broad metaphyses are due to enlargement of the spongy inner layer of bone. Although trabecular bone is expanded, the dense outermost layer of bone is thinner than normal. As a result, the bones are fragile and fracture easily. The bone abnormalities in the legs commonly cause knock knees in affected individuals.

Marshall-Smith Syndrome, discovered in 1971, is characterized by unusual accelerated skeletal maturation and symptoms like conspicuous physical characteristics, respiratory difficulties, and mental retardation. Cases described in the literature show a clinical variability regarding related symptoms. For instance, respiratory difficulties are ranging from absent to severe difficulties.

<span class="mw-page-title-main">Antley–Bixler syndrome</span> Medical condition

Antley–Bixler syndrome is a rare, severe autosomal recessive congenital disorder characterized by malformations and deformities affecting the majority of the skeleton and other areas of the body.

<span class="mw-page-title-main">Boomerang dysplasia</span> Medical condition

Boomerang dysplasia is a lethal form of osteochondrodysplasia known for a characteristic congenital feature in which bones of the arms and legs are malformed into the shape of a boomerang. Death usually occurs in early infancy due to complications arising from overwhelming systemic bone malformations.

<span class="mw-page-title-main">Fibrochondrogenesis</span> Medical condition

Fibrochondrogenesis is a rare autosomal recessive form of osteochondrodysplasia, causing abnormal fibrous development of cartilage and related tissues.

<span class="mw-page-title-main">Gerodermia osteodysplastica</span> Medical condition

Gerodermia osteodysplastica (GO) is a rare autosomal recessive connective tissue disorder included in the spectrum of cutis laxa syndromes.

<span class="mw-page-title-main">Spondyloepimetaphyseal dysplasia, Pakistani type</span> Medical condition

Spondyloepimetaphyseal dysplasia, Pakistani type is a form of spondyloepimetaphyseal dysplasia involving PAPSS2. The condition is rare.

Opsismodysplasia is a type of skeletal dysplasia first described by Zonana and associates in 1977, and designated under its current name by Maroteaux (1984). Derived from the Greek opsismos ("late"), the name "opsismodysplasia" describes a delay in bone maturation. In addition to this delay, the disorder is characterized by micromelia, particularly of the hands and feet, delay of ossification, platyspondyly, irregular metaphyses, an array of facial aberrations and respiratory distress related to chronic infection. Opsismodysplasia is congenital, being apparent at birth. It has a variable mortality, with some affected individuals living to adulthood. The disorder is rare, with an incidence of less than 1 per 1,000,000 worldwide. It is inherited in an autosomal recessive pattern, which means the defective (mutated) gene that causes the disorder is located on an autosome, and the disorder occurs when two copies of this defective gene are inherited. No specific gene has been found to be associated with the disorder. It is similar to spondylometaphyseal dysplasia, Sedaghatian type.

<span class="mw-page-title-main">Ischiopatellar dysplasia</span> Medical condition

Ischiopatellar dysplasia is a rare autosomal dominant disorder characterized by a hypoplasia of the patellae as well as other bone anomalies, especially concerning the pelvis and feet. It is also known as small patella syndrome, with earlier synonyms being Scott-Taor syndrome, Coxo-podo-patellar syndrome, Patella aplasia, coxa vara, tarsal synostosis, Congenital coxa vara, patella aplasia and tarsal synostosis ischiocoxopodopatellar syndrome.

Kenny-Caffey syndrome type 2 (KCS2) is an extremely rare autosomal dominant genetic condition characterized by dwarfism, hypermetropia, microphthalmia, and skeletal abnormalities. This subtype of Kenny-Caffey syndrome is caused by a heterozygous mutation in the FAM111A gene (615292) on chromosome 11q12.

<span class="mw-page-title-main">Oto-palato-digital syndrome</span> X-linked recessive genetic disorders

Oto-palato-digital syndrome is the generalised term for two conditions, oto-palato-digital syndrome type I (OPD1) and oto-palato-digital syndrome type II (OPD2), that are both X-linked recessive genetic disorders with overlapping phenotypes. The most severe phenotypes of each syndrome occur only in males, with females generally having attenuated forms of the condition, although this does not apply to all individual cases. Some writers conceptualise oto-palato-digital syndrome as a spectrum disorder including two similarly-presenting genetic syndromes, frontometaphyseal dysplasia and Melnick-Needles syndrome.

Cousin syndrome is a genetic condition characterized by short stature at birth, a short neck with low-positioned external ears, as well as congenital malformations of the skeletal system affecting the shoulders, the pelvis, the neck, and the limbs. The condition determines physical disability, particularly affecting deambulation, and hearing loss while intelligence is not affected.

<span class="mw-page-title-main">Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome</span> Medical condition

Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome is a rare genetic disorder which is characterized by osseous anomalies resulting in short stature and other afflictions.

<span class="mw-page-title-main">Spondyloenchondrodysplasia</span> Medical condition

Spondyloenchondrodysplasia is the medical term for a rare spectrum of symptoms that are inherited following an autosomal recessive inheritance pattern. Skeletal anomalies are the usual symptoms of the disorder, although its phenotypical nature is highly variable among patients with the condition, including symptoms such as muscle spasticity or thrombocytopenia purpura. It is a type of immunoosseous dysplasia.

References

  1. Hoogendam, Jakomijn; Farih-Sips, Hetty; C. Wynaendts, Liliane; W.G.M Löwik, Clemens; M. Wit, Jan; Karperien, Marcel. "Novel mutations in the PTHR1 causing Blomstrand Osteochondrodysplasia type I and II" (PDF). Blomstrand Osteochondrodysplasia: 38.
  2. Eiken, M., Prag, J., Petersen, K. and Kaufmann, H. (1984) A new familialskeletal dysplasia with severely retarded ossification and abnormal modeling of bones especially of the epiphyses, the hands, and feet. Eur. J. Pediatr., 141, 231–235.
  3. "The Many Faces of PTHR1 Mutations". Growth, Genetics & Hormones. 21 (2). June 2005.
  4. "Eiken syndrome (Concept Id: C1838779) - MedGen - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2023-12-13.
  5. 1 2 Portales-Castillo, Ignacio; Dean, Thomas; Cheloha, Ross W.; Creemer, Brendan A.; Vilardaga, Jean-Pierre; Savransky, Sofya; Khatri, Ashok; Jüppner, Harald; Gardella, Thomas J. (2023-06-02). "Altered Signaling and Desensitization Responses in PTH1R Mutants Associated with Eiken Syndrome". Communications Biology. 6 (1): 599. doi: 10.1038/s42003-023-04966-0 . ISSN   2399-3642. PMC   10238420 . PMID   37268817.
  6. Cole, William G. (2013), "Skeletal Dysplasias", Genetics of Bone Biology and Skeletal Disease, Elsevier, pp. 325–336, doi:10.1016/b978-0-12-387829-8.00021-4, ISBN   978-0-12-387829-8 , retrieved 2023-12-13
  7. Jacob, Prince; Soni, Jai P.; Mortier, Geert; Girisha, Katta M. (2019-07-11). "The third family with Eiken syndrome". Clinical Genetics. 96 (4): 378–379. doi:10.1111/cge.13601. ISSN   0009-9163. PMID   31297790. S2CID   195893022.

Further reading